Navigation Links
NeurogesX Reports Second Quarter 2008 Results
Date:8/13/2008

Second Quarter 2008 Corporate Highlights: - European marketing application under review for NGX-4010 in peripheral

neuropathic pain - NGX-4010 NDA for PHN on track for submission in second half of 2008

- IND submitted and opened for NGX-1998 liquid capsaicin formulation

- Phase 1 clinical trial of NGX-1998 initiated - Journal Neurology published positive Phase 3 data on NGX-4010 in HIV-DSP

SAN MATEO, Calif., Aug. 13 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for the quarter ended June 30, 2008.

In the second quarter of 2008, the Company continued on its path toward potential commercialization of its lead product candidate, NGX-4010, a dermal capsaicin patch designed for the treatment of certain neuropathic pain conditions. On the U.S. regulatory front, the Company has been preparing a New Drug Application (NDA) to support marketing approval of NGX-4010 for the treatment of post-herpetic neuralgia (PHN), and is on track to submit an NDA to the U.S. Food and Drug Administration (FDA) later this year.

The Company continues to pursue the European approval of its Marketing Authorization Application (MAA) for NGX-4010 in neuropathic pain, which the European Medicines Agency (EMEA) accepted for review in September 2007. In September of 2008, the Company, with the EMEA's agreement, plans to submit responses to the regulatory agency's Day 120 questions, which are part of the review process for the MAA.

In addition to focusing on regulatory activities for NGX-4010, NeurogesX has made significant progress with
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeurogesX to Report Second Quarter 2008 Financial Results
2. NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
3. NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. NeurogesX Reports First Quarter 2008 Results
5. NeurogesX to Report First Quarter 2008 Financial Results
6. NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
7. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
8. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX Closes $25 Million Private Placement
11. NeurogesX, Inc. Announces $25 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... (PRWEB) July 24, 2014 Your ... advances in modeling lithium-ion battery storage capacity. , ... from a theoretical model created at Lawrence ... that predicts how carbon components will perform ... storage emphasizes the urgent need for higher-performance batteries. ...
(Date:7/24/2014)... San Francisco, CA (PRWEB) July 24, 2014 ... Wednesday to be semi-finalists in Livestrong’s Big C Competition. ... Decisive Health are each headed to the semi-final round. ... in Livestrong’s exclusive three-month accelerator program, complete with mentoring ... country. , As part of the angelMD commitment ...
(Date:7/24/2014)... , July 24, 2014 WIRB-Copernicus Group ... regulatory and ethical review services for clinical research, ... Formerly a division of Richmond, VA ... leading biosafety and biosecurity consulting firm in ... addition, WCG,s biosafety division – WCG Biosafety™ – ...
(Date:7/24/2014)... 24, 2014 Draper University, a ... proud to announce that for 6 weeks this ... will converge on the Draper University campus in ... experiential program focused on entrepreneurship, building real-world skills, ... currently running its sixth cohort, continues to refresh ...
Breaking Biology Technology:Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... Space Place , the University of Wisconsin-Madison's astronomy ... Villager Mall, opening Sunday, Aug. 28. Opening week activities continue ... the public. , ,"We had pretty much outgrown our ... Jim Lattis. "Our programming, our attendance has increased steadily every ...
... aside, every biologist knows that men and women truly are ... where those differences come to the fore: around 80 percent ... play behaviors also differ greatly between the sexes - just ... , ,Early in human development, critical brain proteins known as ...
... Technologies, a life sciences nanotechnology company, has received a ... Medical Sciences. , ,The Small Business Innovation Research grant ... crystal based technology to enable faster screening of drugs ... by using liquid crystals to measure topography on a ...
Cached Biology Technology:Space Place opens new astronomy center 2Gender hormones may lend to social disorder therapies 2
(Date:7/24/2014)... on different species of fish, according to a ... Exeter which tested fish anti-predator behaviour. , ... predator model when exposed to additional noise, whereas ... , Lead author Dr Irene Voellmy of Bristol,s ... many aquatic environments have increased substantially during the ...
(Date:7/24/2014)... terroir, meaning the microbial populations found on surfaces in ... the final flavor according to research published ahead of ... . This is the first time investigators have taken ... Many sake makers inoculate with both bacteria and yeast, ... of California, Davis, but he and his colleagues investigated ...
(Date:7/24/2014)... at NJIT this week for an all-day public forum ... Protection Agency (EPA) to dredge toxic sediment from an ... EPA has called the plan, which proposes removing 4.3 ... of the riverbed, one of the largest cleanups in ... and disposed off-site. , "We need to ensure the ...
Breaking Biology News(10 mins):The microbes make the sake brewery 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2
... scientists survey five New York flu seasons , On the ... for Genomic Research (TIGR) have captured influenza evolution in action. ... , the researchers report the first large-scale project to sequence ... the rapidly evolving flu virus in a human population--and a ...
... RNA is enough to clearly distinguish cancerous thyroid tissue ... findings provide more evidence that an emerging set of ... force in the development of cancer and other diseases. ... Proceedings of the National Academy of Sciences. , Scientists ...
... UK have one of the highest rates of resistance to ... a second wave epidemic of resistant virus, a new study ... concerned that the large reductions in deaths and improvements to ... (combination antiretroviral therapy) may be compromised because of this. , ...
Cached Biology News:First big influenza genome study reveals flu evolution 2First big influenza genome study reveals flu evolution 3First big influenza genome study reveals flu evolution 4Role of microRNA identified in thyroid cancer 2Role of microRNA identified in thyroid cancer 3HIV drug resistance increasing in UK and among highest in the world 2
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
Mouse monoclonal antibody raised against a partial recombinant TTC3. NCBI Entrez Gene ID = TTC3...
Mouse polyclonal antibody raised against a partial recombinant SYT4. NCBI Entrez Gene ID = 6860...
Mouse monoclonal antibody raised against a partial recombinant IL31RA. NCBI Entrez Gene ID = IL31RA...
Biology Products: